AWARD/CONTRACT 1.THIS CONTRACT IS A RATED ORDER UNDER DPAS(15 CFR 700) RATING PAGE OF PAGES 1 19 2. CONTRACT (Proc. Inst. Ident.) NO. 3. EFFECTIVE DATE 4. REQUISITION/PURCHASE REQUEST/PROJECT NO. W911QY 20C0077 04 Jun 2020 0011504522 5. ISSUED...Novavax Inc • August 10th, 2020 • Biological products, (no disgnostic substances)
Company FiledAugust 10th, 2020 Industry
SHARE PURCHASE AGREEMENTNovavax Inc • August 10th, 2020 • Biological products, (no disgnostic substances)
Company FiledAugust 10th, 2020 Industry
AWARDEE INFORMATION Name: Novavax, Inc. (“Awardee”) Mailing Address: 21 Firstfield Road, Gaithersburg, MD 20878 Project Lead: [***], Director, Global Program Management Management Contact: [***], SVP, Commercial Strategy Bank Account Details:...Novavax Inc • August 10th, 2020 • Biological products, (no disgnostic substances) • England and Wales
Company FiledAugust 10th, 2020 Industry JurisdictionTHIS AGREEMENT is between Awardee and the Coalition for Epidemic Preparedness Innovations (“CEPI”) and is effective as of the date of the last signature, below (the “Effective Date”). Each party to this Agreement may be referred to individually as a “Party” and together as the “Parties.” This Agreement sets out the terms and conditions governing the performance of the Project, funding of the Project and how the results of the Project shall be used to further CEPI’s mission. As a condition of this funding award, the Parties enter into this Agreement by having their authorized representatives sign below.